| Pradaxa 75 mg hard capsules EU/1/08/442/1-4 |
Dabigatran etexilate |
Boehringer Ingelheim International GmbH |
— |
| Praxbind 2.5 g/50 mL solution for injection/infusion EU/1/15/1056/001 |
Idarucizumab |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.088 mg tablets EU/1/97/050/001-002 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.18 mg tablets EU/1/97/050/003-004 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.26 mg prolonged-release tablets EU/1/97/050/013-015 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.35 mg tablets EU/1/97/050/011-012 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.52 mg prolonged-release tablets EU/1/97/050/016-018 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.7 mg tablets EU/1/97/050/005-006 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 1.05 mg prolonged-release tablets EU/1/97/050/19-21 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 1.57 mg prolonged-release tablets EU/1/97/050/028-30 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 2.1 mg prolonged-release tablets EU/1/97/050/22-24 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 2.62 mg prolonged-release tablets EU/1/97/050/031-33 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 3.15 mg prolonged-release tablets EU/1/97/050/25-27 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| Spiolto Respimat 2.5 microgram/2.5 microgram, inhalation solution PA0775/009/001 |
Tiotropium, Olodaterol |
Boehringer Ingelheim International GmbH |
Marketed |
| SPIRIVA 18 microgram, inhalation powder, hard capsule PA0775/002/001 |
Tiotropium bromide |
Boehringer Ingelheim International GmbH |
Marketed |
| Spiriva Respimat 2.5 microgram inhalation solution PA0775/002/002 |
Tiotropium bromide |
Boehringer Ingelheim International GmbH |
Marketed |
| Striverdi Respimat 2.5 microgram inhalation solution PA0775/006/001 |
Olodaterol |
Boehringer Ingelheim International GmbH |
Marketed |
| Synjardy 12.5 mg/1,000 mg film-coated tablets EU/1/15/1003/028-036 |
Empagliflozin, Metformin Hydrochloride |
Boehringer Ingelheim International GmbH |
— |
| Synjardy 12.5 mg/850 mg film-coated tablets EU/1/15/1003/019-027 |
Empagliflozin, Metformin Hydrochloride |
Boehringer Ingelheim International GmbH |
— |
| Synjardy 5 mg/1,000 mg film-coated tablets EU/1/15/1003/010-018 |
Empagliflozin, Metformin Hydrochloride |
Boehringer Ingelheim International GmbH |
— |
| Synjardy 5 mg/850 mg film-coated tablets EU/1/15/1003/001-009 |
Empagliflozin, Metformin Hydrochloride |
Boehringer Ingelheim International GmbH |
— |
| Trajenta 5 mg film-coated tablets EU/1/11/707/001-011 |
Linagliptin |
Boehringer Ingelheim International GmbH |
— |
| Twynsta 40 mg/10 mg tablets EU/1/10/648/008-014 |
Amlodipine besilate, Telmisartan |
Boehringer Ingelheim International GmbH |
— |
| Twynsta 40 mg/5 mg tablets EU/1/10/648/001-007 |
Telmisartan, Amlodipine besilate |
Boehringer Ingelheim International GmbH |
— |
| Twynsta 80 mg/10 mg tablets EU/1/10/648/022-028 |
Telmisartan, Amlodipine besilate |
Boehringer Ingelheim International GmbH |
— |
| Twynsta 80 mg/5 mg tablets EU/1/10/648/015-021 |
Telmisartan, Amlodipine besilate |
Boehringer Ingelheim International GmbH |
— |
| Vargatef 100 mg soft capsules EU/1/14/954/001-003 |
Nintedanib |
Boehringer Ingelheim International GmbH |
— |
| Vargatef 150 mg soft capsules EU/1/14/954/004 |
Nintedanib |
Boehringer Ingelheim International GmbH |
— |
| Viramune 200 mg tablets EU/1/97/055/001 |
Nevirapine |
Boehringer Ingelheim International GmbH |
— |
| Viramune 400 mg prolonged-release tablets EU/1/97/055/007-009 |
Nevirapine |
Boehringer Ingelheim International GmbH |
— |
| Viramune 50 mg/5 mL oral suspension EU/1/97/055/002 |
Nevirapine hemihydrate |
Boehringer Ingelheim International GmbH |
— |